On October 7, 2025, ASP Isotopes announced it secured a purchase order from a U.S. customer to supply enriched Barium‑137 for quantum‑computing applications, with delivery scheduled for the first quarter of 2026. This contract marks a significant expansion into the quantum‑computing supply chain and represents a new revenue stream for the company.
The Barium‑137 order underscores the growing demand for high‑purity isotopes in scalable quantum‑computing systems, positioning ASP Isotopes as a key supplier in this emerging market. The contract strengthens the company’s specialist isotope portfolio and signals a strategic move into a high‑growth sector.
In the same announcement, ASP Isotopes disclosed that its CEO will take a health‑related leave of absence. The leadership transition may affect short‑term executive oversight, but the company has not indicated any immediate operational disruptions. The announcement signals a change in top management while the company continues to pursue its growth strategy.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.